Stockscreener 앱 받기
1.00
1.96%
-0.02
시간 외 거래:
1.00
전일 마감가:
$1.02
열려 있는:
$0.98
하루 거래량:
109.12K
Relative Volume:
0.71
시가총액:
$25.30M
수익:
-
순이익/손실:
$-3,000
주가수익비율:
0.1983
EPS:
5.0425
순현금흐름:
$-13.22M
1주 성능:
-11.50%
1개월 성능:
-8.26%
6개월 성능:
+18.76%
1년 성능:
+42.88%
1일 변동 폭
$0.98
$1.0399
1주일 범위
$0.98
$1.24
52주 변동 폭
$0.375
$1.45
AEON Biopharma Inc. Stock (AEON) Company Profile
명칭
AEON Biopharma Inc.
전화
(949) 354-6499
주소
5 Park Plaza, Suite 1750, Irvine
Compare AEON vs VRTX, REGN, ALNY, ARGX, INSM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AEON
AEON Biopharma Inc.
|
1.00 | 25.81M | 0 | -3,000 | -13.22M | 5.0425 |
VRTX
Vertex Pharmaceuticals Inc
|
453.74 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
756.73 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.16 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
692.83 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
147.60 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
AEON Biopharma Inc. Stock (AEON) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-08-18 | 개시 | H.C. Wainwright | Buy |
AEON Biopharma Inc. 주식(AEON)의 최신 뉴스
Aeon Biopharma announces FDA feedback after Type 2a meeting - Yahoo Finance
AEON Biopharma receives FDA feedback on botulinum toxin biosimilar - Investing.com
AEON Biopharma Announces FDA Feedback Following BPD Type 2a Meeting for the ABP-450 Biosimilar Program - The Manila Times
FDA maps next steps for AEON's bid to bring a Botox biosimilar - Stock Titan
AEON Biopharma (AEON) Projected to Post Quarterly Earnings on Wednesday - Defense World
If You Invested $1,000 in Aeon Biopharma (AEON) - Stock Titan
AEON Biopharma, Inc.: Fundamental Analysis and Financial Ratings | AEON | US00775E1029 - marketscreener.com
Technical Analysis: Whats the profit margin of AEON Biopharma Inc2026 WrapUp & Weekly Market Pulse Updates - baoquankhu1.vn
Travel Stocks: How much upside does AEON Biopharma Inc haveQuarterly Trade Summary & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Profit Recap: Can AEON Biopharma Inc stock outperform in a bear marketMarket Performance Report & Low Risk Entry Point Guides - baoquankhu1.vn
Risk Analysis: Is AEON Biopharma Inc stock good for income investors2026 Trade Ideas & Safe Entry Point Identification - baoquankhu1.vn
AEON Technical Analysis | Trend, Signals & Chart Patterns | AEON BIOPHARMA INC (NYSEARCA:AEON) - ChartMill
AEON Biopharma (NASDAQ: AEON) CMO granted RSUs and modifies 1,316,872-unit award - Stock Titan
AEON Biopharma names John Bencich as chief financial officer - Investing.com Australia
AEON Biopharma Appoints John Bencich as Chief Financial Officer - The Manila Times
AEON Biopharma Strengthens Finance Leadership with New CFO - TipRanks
AEON Biopharma names John Bencich as chief financial officer By Investing.com - Investing.com Canada
AEON appoints John Bencich as CFO; Jennifer Sy employment terms confirmed - TradingView
New AEON Biopharma (NYSE: AEON) CFO hired as company expands inducement equity pool - Stock Titan
AEON Biopharma, Inc. Appoints John Bencich as Chief Financial Officer, Effective as of March 9, 2026 - marketscreener.com
How cyclical is AEON Biopharma Inc. Class stock compared to rivalsInflation Watch & AI Enhanced Trading Signals - Naître et grandir
AEON Biopharma Abstract Accepted for Presentation at 2026 American Academy of Neurology (AAN) Annual Meeting - The Manila Times
AEON (AEON) CLO adds large stock awards and converts prior RSUs - Stock Titan
AEON Biopharma (AEON) details major stock unit grants to officer - Stock Titan
Botox biosimilar study from AEON Biopharma set for big U.S. neurology meeting - Stock Titan
AEON PE Ratio & Valuation, Is AEON Overvalued - Intellectia AI
Breakout Zone: Is AEON Biopharma Inc stock good for income investorsJuly 2025 Action & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
AEON Technical Analysis & ETF Price Forecast - Intellectia AI
Will AEON Biopharma Inc. outperform small cap indexes2025 Sector Review & Real-Time Volume Triggers - mfd.ru
AEON Biopharma (AEON) CEO awarded 3,000,000 restricted stock units - Stock Titan
AEON (AEON) files resale prospectus for up to 51.3M shares - Stock Titan
Guidance Update: Whats the profit margin of AEON Biopharma IncWeekly Market Outlook & AI Driven Price Forecasts - baoquankhu1.vn
Will AEON Biopharma Inc. stock benefit from commodity pricesJuly 2025 Sentiment & Technical Buy Zone Confirmation - mfd.ru
Short Covering: Can AEON Biopharma Inc. weather a recessionWeekly Trading Summary & Weekly Watchlist of Top Performers - baoquankhu1.vn
Profit Review: Is AEON Biopharma Inc in a long term uptrendMarket Sentiment Summary & Daily Stock Trend Reports - baoquankhu1.vn
Midday Stock Roundup: MDxHealth Up 9% Since Preliminary Q4, FY Results - Orange County Business Journal
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions - The Manila Times
AEON Biopharma completes FDA meeting, shareholders approve transactions - Investing.com
Aeon Biopharma stock falls after FDA meeting and debt restructuring By Investing.com - Investing.com Nigeria
Aeon Biopharma stock falls after FDA meeting and debt restructuring - Investing.com
Aeon Biopharma Reports bpd Type 2A Meeting With FDA And Shareholder Approval Of The November Transactions - TradingView
AEON Biopharma completes FDA meeting, shareholders approve transactions By Investing.com - Investing.com Nigeria
Shareholders back AEON debt-cut deals after FDA meeting on Botox biosimilar - Stock Titan
Growth Value: Is AEON Biopharma Inc stock good for income investorsQuarterly Trade Summary & Community Supported Trade Ideas - baoquankhu1.vn
Is EverQuote Inc. stock attractive for passive investorsWeekly Investment Summary & Long-Term Safe Return Strategies - bollywoodhelpline.com
Midday Stock Roundup: loanDepot Jumps on Trump’s Proposed Mortgage Plan - Orange County Business Journal
Rate Cut: Whats the MACD signal for AEON Biopharma Inc2025 Macro Impact & AI Powered Market Entry Ideas - baoquankhu1.vn
Do Not Use - ocbj.com
Market Wrap: Can AEON Biopharma Inc keep up with sector leadersJuly 2025 Rallies & Risk Controlled Swing Alerts - baoquankhu1.vn
AEON Biopharma (AEON) Price Target Decreased by 14.75% to 5.30 - Nasdaq
AEON Biopharma Inc. (AEON) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.04%
0.06%
자본화:
|
볼륨(24시간):